【摘要】 目的比较不同胰岛素强化治疗对初诊2型糖尿病的疗效。方法将120例初诊2型糖尿病患者按随机数字表法分为2组:诺和锐30组(n=60)每日3次诺和锐30皮下注射;诺和灵组(n=60)每日4次重组人胰岛素治疗(三餐前30 min皮下注射诺和灵R,睡前皮下注射诺和灵N)。结果 2组相比,诺和锐30组血糖达标时间更短(P<0.01),胰岛素用量更少(P<0.01),低血糖发生率更低(P<0.01)。结论诺和锐30每日3次注射可作为初诊2型糖尿病的有效治疗手段之一。更多还原

【Abstract】 Objective To compare the effects of two types of insulin in patients with newly diagnosed type 2 diabetes.Methods A total of 120 patients with newly diagnosed type 2 diabetes were randomized to receive either three-times-daily injections of Biphasic insulin aspart 30(NovoMix 30 group,n=60) or four-times-daily injections of recombinant human insulin Novolin(Novolin group,n=60,Novolin R injections were given 30 minutes before the meal and Novolin N injections at bedtime).Results Compared with Novolin group,blood glucose lowering was faster,and less insulin was required and less hypoglycemia occurred in NovoMix 30 group(all P<0.01).Conclusion Three-times-daily injections of NovoMixR 30 is effective in patients with newly diagnosed type 2 diabetes.更多还原